Brian Leyland - Veröffentlichungen allgemein

(1 - 4 von 6

)

A Review of the Modulation of Cisplatin Toxicities by ...Springer

link.springer.com

von RT Dorr · Zitiert von: 24 — In 1988, Dr. Brian Leyland-Jones questioned “Whither the Modulation of Platinum” in an editorial in the Journal of the National Cancer Institute ... von RT Dorr · Zitiert von: 24 — In 1988, Dr. Brian Leyland-Jones questioned “Whither the Modulation of Platinum” in an editorial in the Journal of the National Cancer Institute ...

Scientific Advisory Board Kenneth J. Pienta, MDOTraces

www.otraces.net

Brian Leyland-Jones M.D.. Dr. Leyland-Jones is the Vice President of Molecular and Experimental Research at the Avera. Cancer Institute and the Director of ...

PI3K-mTOR in Cancer and Cancer Therapy | SpringerLinkSpringer

link.springer.com

von N Dey · Zitiert von: 8 — Brian Leyland-Jones, MB BS, Ph.D. is Vice President of Avera Cancer Institute Center for Precision Oncology. Dr. Leyland-Jones is a consulting professor at the ...

[PDF] 33rd Annual Cancer Progress Conference, May 10th – 12th 2022cancerprogressbycellohealth.com › wp-content › uploads ›

cancerprogressbycellohealth.com

· Brian Leyland Jones, MB BS, PhD, CMO, National Foundation for Cancer Research. • Karen Peterson, TNBC survivor, Founder, Karen's Club.

Verwandte Suchanfragen zu Brian Leyland

Ross Mckitrick

Personen
Vorname "Brian" (12497)
Name "Leyland" (178)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Veröffentlichungen allgemein Brian Leyland

A Review of the Modulation of Cisplatin Toxicities by ...Springer

Scientific Advisory Board Kenneth J. Pienta, MDOTraces

PI3K-mTOR in Cancer and Cancer Therapy | SpringerLinkSpringer

[PDF] 33rd Annual Cancer Progress Conference, May 10th – 12th 2022cancerprogressbycellohealth.com › wp-content › uploads ›